Patents by Inventor Jiao JI

Jiao JI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating cancer by combination of IAP inhibitor and modulator of immune checkpoint molecule
    Patent number: 12186304
    Abstract: The present disclosure pertains to the field of biomedicine, and specifically relates to a method for treating, suppressing, reducing the severity of, lowering the risk of, or inhibiting the metastasis of cancer in an individual, the method comprising administering to the individual a therapeutically effective amount of an IAP inhibitor, a therapeutically effective amount of a modulator of an immune checkpoint molecule, and optionally a therapeutically effective amount of a tubulin inhibitor. The present disclosure further relates to a pharmaceutical composition or kit comprising an IAP inhibitor, a modulator of an immune checkpoint molecule, and optionally a tubulin inhibitor.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: January 7, 2025
    Assignee: Ascentage Pharma (Suzhou) Co., LTD.
    Inventors: Dajun Yang, Yifan Zhai, Douglas Dong Fang, Guangfeng Wang, Qiuqiong Tang, Wentao Pan, Jiao Ji
  • METHOD FOR TREATING CANCER BY COMBINATION OF IAP INHIBITOR AND MODULATOR OF IMMUNE CHECKPOINT MOLECULE
    Publication number: 20210330642
    Abstract: The present disclosure pertains to the field of biomedicine, and specifically relates to a method for treating, suppressing, reducing the severity of, lowering the risk of, or inhibiting the metastasis of cancer in an individual, the method comprising administering to the individual a therapeutically effective amount of an IAP inhibitor, a therapeutically effective amount of a modulator of an immune checkpoint molecule, and optionally a therapeutically effective amount of a tubulin inhibitor. The present disclosure further relates to a pharmaceutical composition or kit comprising an IAP inhibitor, a modulator of an immune checkpoint molecule, and optionally a tubulin inhibitor.
    Type: Application
    Filed: July 30, 2019
    Publication date: October 28, 2021
    Inventors: Dajun YANG, Yifan ZHAI, Douglas Dong FANG, Guangfeng WANG, Qiuqiong TANG, Wentao PAN, Jiao JI